-- 2026年4月14日,董事、总裁兼首席执行官马歇尔·福代斯(Marshall Fordyce)出售了Vera Therapeutics (VERA)的22,951股股票,套现1,011,051美元。根据向美国证券交易委员会(SEC)提交的4号表格文件,福代斯目前控制着该公司共计457,274股A类普通股,其中235,244股为直接持有,222,030股为间接控制。 SEC文件链接: https://www.sec.gov/Archives/edgar/data/1831828/000185945326000006/xslF345X05/form4-04152026_080434.xml
Related Articles
Sunshine Metals Completes Resource Definition Drilling at Queensland Gold-Dominant Deposit
Sunshine Metals (ASX:SHN) completed resource definition drilling at the Liontown gold panel, a gold-dominant deposit which is part of its Ravenswood consolidated project in Queensland, in late March, according to a Monday Australian bourse filing.The mining study and mineral resource for the Liontown project will be further updated and upgraded in May to incorporate results from the grade control drilling program.
Wanxiang Qianchao Q1 Profit Down 16%; Shares Slide 3%
Wanxiang Qianchao (SHE:000559) posted first-quarter attributable net profit of 246.8 million yuan, down 16% from 293.3 million yuan the previous year.Earnings per share declined to 0.074 yuan from 0.089 yuan, according to a weekend filing with the Shenzhen bourse.Operating revenue slipped 20% year over year to 2.80 billion yuan from 3.50 billion yuan.Shares of the auto parts manufacturer declined 3% in recent trade.
Eng Kah Seeks 10% Share Buyback Mandate; Shares Rise 3%
Eng Kah (KLSE:ENGKAH) is seeking its shareholders' approval to renew share buyback authority to purchase up to 10% of the issued shares in the company's upcoming annual general meeting, according to a Friday Malaysian bourse filing.Shares gained about 3% in Monday's afternoon trade.The manufacturer of cosmetics, personal care, household, and perfume products will share a detailed statement of the repurchase plan with shareholders in due time.